LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Oregon OR
Legislatures
2025 Regular Session
House
Bills
HB2599
OR
Oregon House Bill HB2599
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Oregon 2025 Regular Session
Oregon House Bill HB2599
Introduced
1/13/25
Refer
1/17/25
Caption
Relating to the Prescription Drug Affordability Board; prescribing an effective date.
Latest HB2599 Activity
Companion Bills
No companion bills found.
Previously Filed As
OR SB404
Relating to prescription drugs; prescribing an effective date.
OR SB192
Relating to prescription drugs; and prescribing an effective date.
OR HB3258
Relating to prescription drug monitoring; and prescribing an effective date.
OR HB2630
Relating to exemption of prescription drug sales; prescribing an effective date.
OR SB61
Relating to exemption of prescription drug sales; prescribing an effective date.
OR SB716
Relating to off-label indications for prescription drugs; prescribing an effective date.
OR HB2642
Relating to prescription drug monitoring; prescribing an effective date.
OR HB2760
Relating to exemption of prescription drug sales; prescribing an effective date.
OR HB3444
Relating to health care; prescribing an effective date.
OR SB254
Relating to drugs; prescribing an effective date.
Similar Bills
CA AB2789
Health care practitioners: prescriptions: electronic data transmission.
CA AB852
Health care practitioners: electronic prescriptions.
CA AB149
Controlled substances: prescriptions.
TX HB2246
Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.
TX SB594
Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.
TX HB2766
Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.